Stocktoria
LABCORP HOLDINGS INC. LH
NYSE · XNYS · stock · Services-Medical Laboratories · website · IPO 1991-04-24
LABCORP HOLDINGS INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $14.0B | $13.0B | $12.2B | $11.9B | $13.1B |
| Gross profit | $4.0B | $3.6B | $3.4B | $3.7B | $5.0B |
| SG&A expense | $2.2B | $2.2B | $2.0B | $1.8B | $1.7B |
| Operating income | $1.4B | $1.1B | $725.6M | $1.4B | $3.0B |
| Interest expense | $224.1M | $208.3M | $199.6M | $179.8M | $211.8M |
| Income tax | $229.8M | $212.4M | $188.5M | $233.9M | $690.0M |
| Net income | $876.5M | $746.0M | $418.0M | $1.3B | $2.4B |
| EPS (diluted) | $10.46 | $8.84 | $4.77 | $13.97 | $24.39 |
| Operating cash flow | $1.6B | $1.6B | $1.3B | $2.0B | $3.1B |
| Free cash flow | $1.2B | $1.1B | $874.1M | $1.5B | $2.7B |
| Cash & equivalents | $532.3M | $1.5B | $536.8M | $320.6M | $1.5B |
| Inventory | $534.7M | $493.2M | $474.6M | $470.6M | $401.4M |
| Total assets | $18.4B | $18.4B | $16.7B | $20.2B | $20.4B |
| Total liabilities | $9.8B | $10.3B | $8.8B | $10.0B | $10.1B |
| Shareholders' equity | $8.6B | $8.1B | $7.9B | $10.1B | $10.3B |
Source: SEC EDGAR filings · CIK 0000920148 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.